World1h ago
AstraZeneca-Daiichi breast cancer drug cleared for NHS use in England
LONDON: AstraZeneca and Daiichi Sankyo said on Thursday their breast cancer treatment Enhertu has been approved for use in England’s state-run health care system, expanding access to a drug that has been available in Scotland since 2023. The companies said they will now seek approval for access from health bodies in Wales and Northern Ireland. The approval by the National Institute for Health and Care Excellence (NICE) clears a key hurdle to wider adoption in the UK after funding for Enh
This story was originally reported by Arab News. As an automated real-time news aggregator, NewsToolBar provides multi-perspective indexing and AI summarization while directing full readership directly to primary publisher sources.
ALSO REPORTED BY OTHER SOURCES (2)
New hope for breast cancer patients as life-extending drug now on NHS in England
Cancer patient told she will get drug which will make her life longer. #BBCNews
Community Sentiment & Coverage Reliability
Crowd-sourced evaluation based on verified reader feedback
Rate Coverage Tone:
No reader evaluations recorded yet — be the first to rate the coverage tone above!
Quick Story Reactions:
Community Discussion (0)
Join the Community Discussion
Sign in or create a free reader account to post comments, upvote analysis, and share your perspective.